CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Operating income 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) annual operating income history from SEC filings — each fiscal year as reported.
$27.9MFY2026 · since FY2024: $28.5M → $27.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $27.9M | +5.3% |
| FY2025 | $26.5M | -7.0% |
| FY2024 | $28.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net incomeCUVL Net marginCUVL Gross profitCUVL Gross marginCUVL Operating marginCUVL Operating cash flowCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Total liabilitiesCUVL Shareholders’ equityCUVL overview →